Alpha Tau Medical
DRTS
24 hedge funds and large institutions have $4.95M invested in Alpha Tau Medical in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
68% more capital invested
Capital invested by funds: $2.94M → $4.95M (+$2.01M)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 23 → 24 (+1)
0.21% more ownership
Funds ownership: 1.67% → 1.87% (+0.21%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$1.28M |
| 2 |
Renaissance Technologies
New York
|
+$82.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.7K |
| 4 |
AI
Atom Investors
Austin,
Texas
|
+$9.88K |
| 5 |
Mariner
Overland Park,
Kansas
|
+$8.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
-$84.5K |
| 2 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
-$60.5K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$53.2K |
| 4 |
UWM
USAdvisors Wealth Management
Eden Prairie,
Minnesota
|
-$26K |
| 5 |
Morgan Stanley
New York
|
-$13.5K |
DRTS Hedge Fund Activity: Q2 2025 in Review
24 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2025, worth a combined $4.95M — up 68% from $2.94M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DRTS positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 4 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $1.28M. The largest seller was Levin Capital Strategies, cutting an estimated $84.5K.
- 24 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2025, up from 23 in Q1 2025.
- Funds reported $4.95M of Alpha Tau Medical stock for Q2 2025, up 68% quarter-over-quarter.
- 3 funds opened new Alpha Tau Medical positions in Q2 2025 and 2 closed out, a net change of +1 holder.
- The largest Alpha Tau Medical buyer in Q2 2025 was HighTower Advisors, an estimated $1.28M added.
- The largest Alpha Tau Medical seller in Q2 2025 was Levin Capital Strategies, an estimated $84.5K sold.
Based on aggregated 13F filings for Q2 2025.